3rd Digital Strategy & Innovation for Medical Affairs Summit

Create a Digital Cultural Transformation Within Medical Affairs

February 23-24, 2021

Philadelphia, PA

Event Overview

With a greater demand for deep scientific information across the healthcare community, 
it’s critical for medical affairs teams to upskill and stay relevant as consumers use new channels to absorb information. Learn to transform your medical affairs department, implement progressive policies, push patient centricity, and determine what it takes to demonstrate value to internal and external stakeholders in a digital era. 

For the 3rd Annual DGE Digital Strategy & Innovation for Medical Affairs Summit, we’ve partnered with the brightest in the industry to build a program that focuses on the cultural digital transformation in medical affairs. Join us for the opportunity to participate in an interactive meeting that will help to identify best practices when implementing a digital strategy within your medical affairs team. 

Hilton East Brunswick

Image

3 Tower Center Blvd.
East Brunswick, NJ 08816

(732) 828-2000

Hotel Website

About the Chairperson

Image

Dr. Matthew T. Roe has been a faculty member at Duke University School of Medine and the Duke Clinical Research Institute (DCRI) since 1999. As a senior investigator at the DCRI, he has been the principal investigator for numerous phase II-IV cardiovascular clinical trials and is currently a co-principal investigator for the ADAPTABLE trial—the first large-scale pragmatic trials being conducted in the PCORnet network. He has also served in leadership roles for several observational registries focusing upon the treatment and outcomes of patients with cardiovascular disease and has served as the Director of the DCRI Clinical Research Fellowship since 2010.

Featured Speakers

Image

Craig Lipset

Head of Clinical Innovation
Pfizer

Image

Jeff Kingsley

Chief Executive Officer
IACT Health 

Image

Dawn Anderson

Managing Director, Life Sciences Strategy and Operations, R&D Practice
Deloitte

Image

Ross Friedberg

General Counsel & Chief Privacy Officer
Doctor on Demand

Top Reasons to Attend

  1. Understand the current landscape and what companies are doing with digital strategy
  2. Learn about new digital strategies and how to implement them
  3. Gain a clear understanding of what can be done successfully today in Med Affairs with digital
  4. Learn about ongoing digital initiatives across the industry
  5. Bring back innovative ideas to share data with your team
  6. Updates on digital innovation applications in pharma
  7. Discuss what new digital initiatives medical affairs colleagues are launching in Biotech/Pharma
  8. Examine ideas for sharing real time, on demand scientific content
  9. Learn about digital med info efforts
  10. Discuss budget/pricing for digital innovation applications, implementation challenges and key learnings from successes & failures

Attendee Profile

Current medical affairs professionals:

  • Field Medical Team
  • MSL
  • Medical Affairs
  • Medical Communication
  • Medical Information
  • Digital Strategy
  • Medical Director
  • Medical Advisor
  • Medical Liaison
  • Medical Advisor
  • MSL Coordinator
  • Clinical Development
  • Publications
  • Medical Education Manager
  • Global Medical Affairs
  • Medical Manager
  • Those professionals working within Clinical Development, Research & Development and are transitioning to a medical affairs role
  • Physicians, pharmacists, and PhD professionals wishing to transition into the pharmaceutical industry

Monday

October 19th, 2020 | Day 1

8:00 AM - 9:00 AM

Registration & Continental Breakfast

9:00 AM - 9:15 AM

Conference Opening Remarks

9:15 AM - 10:00 AM

Paper to Hybrid to eTMF – Best Practices for Selecting, Implementing, Transitioning and Assuring Compliance from Day One

Maha Saad, Ph.D., MBA - Americas Pharmacovigilance Head, Bioresearch Quality and Compliance, Quality Assurance
JOHNSON & JOHNSON

10:00 AM - 10:45 AM

Moving Toward a Risk-based eTMF Operating Model

Laura Naranjo - Associate Director, TMF Operations
DAIICHI SANKYO, INC.

10:45 AM - 11:00 AM

Morning Networking Break

11:00 AM - 12:00 PM

Using Metrics to Optimize Business Decisions

REGENERON PHARMACEUTICALS, INC.

12:00 PM - 1:00 PM

Networking Lunch

1:00 PM - 1:45 PM

Sponsor Opportunity

1:45 PM - 2:45 PM

TMF Inspection Readiness

2:45 PM - 3:00 PM

Afternoon Networking Break

3:00 PM - 4:00 PM

Best Practices for Compliant eTMF Archiving

REGENERON PHARMACEUTICALS, INC.

4:00 PM - 4:45 PM

TMF Governance

4:45 PM - 5:00 PM

Day 1 Closing Remarks

FEATURED SPEAKERS

Image

Oscar Segurado

ASC Therapeutics

Chief Medical Officer

Image

Judy Hsiung

Arena Pharmaceuticals

Vice President Safety & Pharmacovigilance

Image

Israel Gutierrez

Geron Corporation

Vice President, Pharmacovigilance and Drug Safety

Image

Joan A. Chambers

The Center for Information & Study on Clinical Research Participation (CISCRP)

Senior Director, Marketing & Outreach

Image

Michael Forstner

PrimeVigilance

Senior Vice President and Head of Pharmacoepidemiology and Risk Management

Image

Sheila Bose

SB Lifesciences Consulting, Inc

President

Image

Christine Von Raesfeld

More Than Lupus

Patient Advocate and Board Member

Image

Angela Ramirez Holmes

Cal Rare

Founder/President

CONFERENCE REGISTRATION


ATTENDEE PRICING

* Super Early Bird *

Before 11/20/20

$1,596

Early Bird

Before 12/18/20

$1,796

Standard

Register Before Event

$1,996

On-Site

Register at Event

$2,196

VIRTUAL LIVE-STREAM PRICING

Register Anytime

$896

Register 2 Attendees, Get 1 Complimentary Registration*!

Interested in sending groups of 7 or more? Contact us directly for pricing.

EVENT SPONSORS



SPONSOR THIS EVENT

Contact Amy Chapman at (561) 571-7687
or achapman@dgeconfs.com


MEDIA PARTNERS

Image

PREMIER MEDIA PARTNER


Why Become Board Certified in Medical Affairs?

Image

Certification is becoming an important factor in the healthcare industry in general. A survey of over 1000 key opinion leaders (KOLs) found that over 90% preferred medical affairs professionals who had a Board Certified Medical Affairs Specialist (BCMAS) designation.

Several pharmaceutical companies also look at certification as a way to assess whether an individual possesses the skills and knowledge required for successful performance in a medical affairs role. Why are companies looking for this assurance? They want to hire the best of the best. By becoming board certified in your field of expertise, and by maintaining BCMAS, you are saying that you:

  • Have met standards that have been established and verified by a credible, accrediting body.
  • Are dedicated to maintaining quality of excellence in your profession.

These are powerful statements that speak volumes about you as a professional and the company or organization you represent. Board certification demonstrates that you are committed to your profession and that you want to continue to learn and grow.
Studies have shown that individuals who are certified in their field have higher salaries and better promotion opportunities.

Top 5 Reasons Why You Should Certify with the ACMA:

  1. Accredited: The ACMA is recognized nationally & internationally as a true mark of quality and excellence in the pharmaceutical industry for medical affairs professionals. The ACMA is accredited by the International Association for Continuing Education & Training (ANSI/IACET) which is the gold standard for certification & training around the world. Our program is administered and analyzed using the highest industry standards and state-of-the-art psychometric methodologies.
  2. Distinguish Yourself: Because ACMA offers multiple but related certificates, you can more readily become certified in more than one specialty, making you more valuable and marketable in the field.
  3. Go International: ACMA certification is widely accepted throughout the US as well as internationally with 25% of BCMAS graduates coming from outside the US.
  4. Expand Your Network: Once certified by ACMA you automatically become a member of the 75,000+ strong ACMA organization and gain access to a multitude of benefits, including discounts on continuing education, leadership opportunities, and access to a mentor to help you get ahead.
  5. Be on the cutting edge: ACMA board certification in medical affairs is the future of the life sciences and pharmaceutical industry.

Interested in BCMAS?

By attending any DGE/ACMA conference, receive 10% off of BCMAS registration.

Already BCMAS Certified? Receive 10% off your conference registration!